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Summary 
We have generated an acid sphingomyelinase (aS- 
Mase)-deficient mouse line by gene targeting. This 
novel strain of mutant mouse mimics the lethal, neu- 
rovisceral form of the human sphingomyelin storage 
disease, known as Niemann-Pick disease. Homozy- 
gous mice accumulate sphingomyelin extensively in 
the reticuloendothelial system of liver, spleen, bone 
marrow, and lung, and in the brain. Most strikingly, the 
ganglionic cell layer of Purkinje cells of the cerebellum 
degenerates completely, leading to severe impairment 
of neuromotor coordination. The Niemann-Pick mouse 
might facilitate studies on the function of aSMase in 
the generation of ceramide as proposed second mes- 
senger in the intracellular signaling pathways and 
across the plasma membrane. Furthermore, it pro- 
vides a suitable model for the development of strate- 
gies for somatic gene therapy. 
Introduction 
Sphingomyelin is a main lipid constituent of the plasma 
membrane and of plasma membrane-derived membranes 
(e.g., endosomes l lysosomes)  of mammalian cells. Lyso- 
somal acid hydrolases play an important role in the turn- 
over of membrane lipids of any cell. Among them, acid 
sphingomyelinase (aSMase, sphingomyelin phosphodies- 
terase, EC 3.1.4.12) hydrolyzes sphingomyelin to cera- 
mide and phosphocholine. The enzyme is present in endo- 
somes/lysosomes of all cells but particularly in cells of the 
reticuloendothelial system (RES) of liver (Kupffer cells), 
spleen, bone marrow, lung, and in macrophages. The au- 
tosomal recessive disease known as Niemann-Pick dis- 
ease (Brady, 1987; Klenk, 1935; Niemann, 1914; Pick, 
1927) is characterized by a partial or complete loss of 
acid sphingomyelinase. Niemann-Pick disease occurs in 
different phenotypes: the neurovisceral type A (NPA) and 
the visceral, nonneuropathic form, type B (NPB). The se- 
verity of symptoms is greater and the life span shorter in 
NPA patients than in NPB patients. A third form, Niemann- 
Pick disease type C, is a lipidosis nosologically totally dif- 
ferent from types A and B. It is not primarily caused by a 
loss of sphingomyelinase activity (Crocker, 1961). Choles- 
terol is stored in vesicles intracellularly (Vanier et al., 
1991). 
The recent isolation and characterization of human aS- 
Mase and the cloning and sequencing of the cDNA (Quin- 
tern et al., 1989) and the coding sequence of the human 
gene (Newrzella and Stoffel, 1992; Schuchman et al., 
1991) revealed that aSMase is a 627 amino acid residue 
glycoprotein of 64 kDa that is encoded in six exons. The 
gene is distributed over approximately 5 kb in the asmase  
locus on chromosome 11 pl 5.1-15.4 (Pereira et al., 1991). 
Several different mutations, so far mostly point mutations, 
in the human asmase  gene have been found that cause 
NPA or NPB. The mutations lead either to a complete loss 
or to a residual aSMase activity (0%-10% of normal ac- 
tivity). The molecular basis of the development of the 
neurovisceral (type A) and visceral form~ (type B) is not 
understood. Existing animal models are insufficiently 
characterized on the genetic level (Bundza et al., 1979; 
Fredrickson et al., 1969; Snyder et al., 1982). They repre- 
sent mostly type C Niemann-Pick phenotypes. 
We recently isolated and characterized the mouse as- 
mase  gene (Newrzella and Stoffel, 1992). Sequence com- 
parison indicates that the mouse and human asmase  
genes are highly similar in size, gene organization, and 
nucleotide sequence of exons and introns. 
Here we report the generation and characterization of 
an aSMase-deficient mouse line. Mice were generated by 
gene targeting using homologous recombination i  embry- 
onic stem (ES) cells. We have disrupted the wild-type as- 
rnase gene in exon III by the insertion of the neomycin 
(neo) resistance gene. 
The phenotype of the asmase  -I- mouse mimics the neu- 
rovisceral form of human Niemann-Pick disease (type A): 
the RESs of liver (Kupffer cells) and of spleen and bone 
marrow, and macrophages of the lung are loaded with 
sphingomyelin stored in vesicular structures. 
The most striking observation in homozygous mutant 
mice is the complete degeneration of the ga.nglionic Pur- 
kinje cell layer of the cerebellum with the progression of 
the storage disease, associated with severe impairment 
of motor coordination. The life span of the Niemann-Pick 
mouse is limited to approximately 4-6 months. 
Results 
Generation of aSMase-Deficient Mice 
The molecular cloning of the asmase  of the mouse and 
the organization and complete nucleotide sequence of the 
gene have been described previously (Newrzella nd Stof- 
fel, 1992). The targeting construct for homologous recom- 
bination in ES cells harbors the complete asmase  gene 
as a 4.8 kb BamHI fragment, starting 781 bp upstream of 
the ATG start codon and ending 160 bp downstream of 
the polyadenylation site. Exon III (174 bp) has been dis- 
rupted by the insertion of the neo gene in sense orienta- 
tion. Transcription of the altered asmase gene is termi- 
nated by the polyadenylation signal of the neo box and 
translation by several stop cod6ns upstream of the neo 
cassette. Four ES cell clones carrying the targeting re- 
placement construct in the asmase  locus were obtained 
by electroporation. They were transferred into blastocysts 
of C57BL/6 donors, which were used for the generation 
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of male chimeric mice. Cross-breeding of chimeric males 
with C57BL/6 females yielded heterozygotes, which were 
intercrossed to btain homozygous mutant mice. For the 
analysis of genomic DNA of ES cells and for allelic typing 
of transgenic mice, tail DNA of chimeric mice and of het- 
erozygous and homozygous offspring was isolated and 
digested with EcoRl. Southern blot analysis was per- 
formed by using the 3' and neo probes indicated in Figure 
1A. The expected sizes of fragments hybridizing with the 
3' and neo probes are given below the corresponding wild- 
type (asmase  +/+) and mutant (asmase  -~-) alleles. The re- 
lease of a 3 kb EcoRI fragment indicated the mutant allele 
and a 2.3 kb fragment the wild-type allele, respectively. 
Polymerase chain reaction (PCR) analysis with the 5' 
and 3' primers (Figure 1A) was carried out to confirm the 
homologous recombination event further. The 1.55 kb 
PCR fragment expected from use of the 5' and 3' primers 
(Figure 1B) was obtained only with the mutant allele as 
template. 
Deve lopment  o f  aSMase-Def i c ient  Mice  
The asmase  mutant mice developed indistinguishably 
from the wild type for a period of 8 -10 weeks. At this point, 
the homozygous mutant mice developed a fine tremor of 
the whole body and a severe intention tremor, and their 
gait became increasingly ataxic: tottering with zigzag 
movement,  characteristic of cerebellar dysfunction. 
Figure 1. Generation of aSMase-Deficient Mice 
(A) Schematic presentation ofthe wild-type asmase mouse gene, the 
asmase replacement vector, and the mutant targeted allele. The tar- 
geting construct for homologous recombination in ES cells harbors 
the complete asmase gene as a 4.8 kb BamHI fragment, starting 781 
bp upstream of the ATG start codon and ending 160 bp downstream 
of the polyadenylation site (Newrzella and Stoffel, 1992). Closed boxes 
indicate exons I-V I, the solid line extragenic sequences of the asmase. 
The neo cassette driven by the tk promoter (stippled box) was inserted 
into the Bcll site of exon III, the thymidine kinase gene (tk) 5' to the 
asmase gene for negative selection (opSn box). For the detection of 
homologous recombinants, genomic DNA of ES clones and tail DNA 
of chimeric mice Was isolated and digested with EcoRI. The expected 
sizes of fragments hybridizing with the 3' and neo probe are indicated 
below the corresponding wild-type and mutant asmase loci. Restriction 
enzymes: B, BamHI; C, Bcll; E, EcoRI; V, EcoRV; H, Hindlll; X, Xbal. 
(13) Southern blot hybridization analysis of tail DNA of ES cell clones 
(+/- ES), wild-type mice (+/+ wt), chimeric mice (+/- ch), heterozygous 
mice (+/-), and homozygous (-/-) mice. Tail DNA was digested with 
EcoRI, size-fractionated by agarose gel electrophoresis (0.8%), blot- 
ted to gene screen filter, and hybridized with the 1.3 kb 3' fragment 
of the asmase DNA (top) and the neo probe (center), as indicated in 
(A). Wild-type mice (+/+ wt), ES cells (+/- ES), chimeric mice 
(+/- ch), heterozygous mice (+/-), and homozygous mice (-/-). Bot- 
tom, PCR analysis. Positions of the primers used for the PCR are 
indicated in (A). The 3' oUgodesoxyinucleotide primer hybridizes out- 
side of the 3' end (Xhol insertion site) of the replacement argeting 
construct; the 5' primer (neo 3') is positioned in the neo gene. The 
1.55 kb PCR fragment indicates the presence of the neo cassette in 
the 3 kb EcoRI fragment in homologous recombined hetero- (+/-) and 
homozygous (-/-) mice. The order of the lanes is the same as that 
given for the Southern blot analysis (upper two panels). Vector: DNA 
contains the complete replacement asmase knockout construct out 
of which the Xhol fragment was isolated and used for electroporation 
of ES cells. 
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Figure 2. asmase mRNA Is Absent in the Total RNA of Liver, Spleen, 
Brain, and Lung of Homozygous asmase -/- Mice 
Northern blot hybridization analysis of liver, spleen, and brain RNA. 
Total RNA of wild-type (C57BL/6) mice and hetero- and homozygous 
mutant mice was separated by form aldehyde-agarose (1.20/o) gel elec- 
trophoresis, transferred to a gene screen membrane, hybridized with 
a randomly labeled full-length asmase cDNA, and compared with ose 
of the intrinsic GAPDH, which was probed with a GAPDH-specific 
cDNA fragment as a control. The intensities of the hybridization signals 
were quantified by use of a Phosphorimager (Molecular Dynamics). 
Hepatosplenomegaly becomes visible around day 60 
after birth, in the final stage, around day 120 afterbirth, the 
mutant mice become severely dyspneic. This pulmonary 
distress leads to severely restricted physical activity and 
finally to death. The life expectancy of aSMase-deficient 
mice is around 4 months. 
A 
geno- protein dpm % spec. 
type (I.tg) activity act. 
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liver +/+ 25 8743; 8464 2728; 1931
4- 0; 0 317; 371 
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Figure 3. Homozygous Mice Show a Complete Lack of aSMase but 
Not of nSMase 
Enzyme assays of aSMase and nSMase of wild-type and asmase -~- 
mice are recorded as dpm, released from [methyl-l~C]sphingomyelin 
during the 1 hr incubation at 37°C. 
(A) The 18,000 x g supernatant ofhomogenized and detergent-lysed 
specimen of liver, spleen, and brain tissue were assayed for aSMase 
activity by incubating the respective cell extract with the labeled 
[methyl-14C]sphingomyelin substrate. The water-soluble radioactivity 
released uring the reaction was measured. 
(B) The residual neutral sphingomyelinase (nSMase) in liver, spleen, 
lung, and brain was assayed at neutral pH (pH 7.4), with the homoge- 
nate (600 x g) of the respective tissues containing the nSMase resi- 
dent in the plasma membrane. Aliq uots (10 pg and 25 p,g) of the homog- 
enates of the respective tissues were used as enzyme sources. 
Characterization of asmase Deficiency 
in Mutant Mice 
asmase mRNA Is Absent in All Organs 
The neo resistance gene introduced into exon III of the 
asmase  gene disrupts the coding region at amino acid 
370. Northern blot analysis of total RNA of liver, spleen, 
and brain of homozygous asmase  -~- mice revealed no as-  
mase-spec i f i c  transcripts, neither truncated nor full length, 
when a full-length asmase  cDNA fragment was used as 
probe (Figure 2). A faint high molecular transcript hybrid- 
izes with the cDNA and neo probes. Hybridization with 
a neo probe indicated that the size of this transcript is 
approximately 3.6 kb, which is the size of a readthrough 
transcript (asmase  mRNA plus neo gene). The 2.4 kb as- 
mase  mRNA of heterozygous mutants was reduced to ap- 
proximately one half, as estimated from the intensities of 
the hybridization signals, which were quantified by a Phos- 
phorimager (Molecular Dynamics) and compared with 
those of the intrinsic glyceraldehyde 3-phosphate dehy- 
drogenase (GAPDH) monitored by a specific cDNA probe 
as a control. The structure of the 3.6 kb transcript was also 
verified by reverse transcription-PCR using appropriate 
primers of asmase  exon III and the neo box (data not 
shown). 
t 
Homozygous asmase Mutant Mice Completely Lack 
aSMase but not Neutral Sphingomyelinase Activity 
aSMase and the residual neutral sphingomyelinase 
(nSMase) were assayed in total protein extract of liver, 
spleen, and brain of wild-type mice and hetero- and homo- 
zygous mutants. The release of the [methyl-14C]phoshoryl- 
choline group from [methyl-14C]sphingomyelin into the 
aqueous phase was measured. No aSMase activity was 
measurable in the homozygous mutants, and a reduction 
to approximately one half was found in the heterozygous 
mutants (Figure 3). 
Residual nSMase in liver, spleen, lung, and brain was 
assayed under neutral reaction conditions (pH 7.4). The 
homogenate of the respective tissues containing the 
nSMase resident in the plasma membrane (600 x g super- 
natant) was assayed for sphingomyelinase activity. The 
analyses of aSMase with the-homogenates as enzyme 
source match those obtained with the 18,000 x g superna- 
tant of liver, spleen, and brain of wild-type, asmase  +~-, and 
asmase  -~- mice. Under the assay conditions for nSMase, 
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Figure 4. Total Lipid Extracts of Liver, Spleen, and Brain Show Mas- 
sive Accumulation of Sphingomyelin 
(A) Total lipid extracts of liver, spleen, and brain of wild-type mice and 
hetero- and homozygous mutant mice were separated by TLC. 
(B) Ester lipids were saponified and the alkali-stabile lipids separated 
in the same solvent system (chloroform-methanol-water, 65:25:4). 
Bands were visualized with a sulphuric acid spray. Phospholipids 
among the total and alkali-stabile lipids were also stained with Zin- 
zadze reagent (Dittmer and Lester, 1964). Abbreviations: C, choles- 
terol; cer, cerebroside; PE, phosphatidylethanolamine; sulf, sulfatide; 
PC, phosphatidylcholine; SPM, sphingomyelin. 
25%-30% of the aSMase activity of the respective tissue 
is still measurable at pH 7.4. This has been demonstrated 
with purified human aSMase (unpublished data). There- 
fore, the numbers in Figure 3 for nSMase activity of as- 
mase +~- and asmase  -~- mice must be corrected by this 
contribution of aSMase. The SMase activity in asmase~ ~- 
liver, spleen, and brain reflects the actual nSMase activity 
in the respective tissues. Thus, nSMase activity is appar- 
ently not altered by the loss of aSMase expression. 
Interestingly, Figure 3 indicates that nSMase activity in 
brain of wild-type mice is three times higher than aSMase 
activity, nSMase in homozygous asmase  -~- mice is only 
slightly reduced as compared with its levels in parenchy- 
mous tissues rich in RES such as spleen, liver, and lung. 
Lipid Analysis of Wild.Type Mice and Hetero- 
and Homozygous Mutant Mice 
Sphingomyelinase-deficient mice accumulate large 
amounts of sphingomyelin in RES cells. We limited the 
analysis of total lipids to the liver, spleen, and brain, which 
are of central interest in NPA and NPB. Total lipids were 
extracted with chloroform-methanol from liver, spleen, 
and brain specimens of wild-type mice and hetero- and 
homozygous mutant mice. Aliquots f the total lipid ex- 
tracts were saponified. Esterlipids were hydrolyzed to wa- 
ter-soluble potassium salts of fatty acids and the polar 
head group components (glycerol, phosphate, and the re- 
spective bases). Sphingomyelin and theother sphingoli- 
pids are alkali resistant and therefore dissolve together 
with cholesterol in the chloroform phase. Figure 4 presents 
the thin-layer chromatograms (TLC) of total and alkali- 
stabile lipids of the liver, spleen, and brain of wild-type 
mice and hetero- and homozygous mutant mice. Compo- 
nents of total lipid extracts (Figure 4A) and unsaponifiable 
lipids (sphingomyelin, cerebrosides, sulfatides, ganglio- 
sides, and cholesterol; Figure 4B) were visualized with 
sulphuric acid. Phospholipids present in the total lipid ex- 
tract and among the unsaponifiable lipid componentswere 
visualized with Zinzadze reagent (data not shown). 
The most prominent lipid in theliver and spleen of homo- 
zygous mutant mice is sphingomyelin. The accumulation 
of sphingomyelin is also visible in the lipid extract of brains, 
although it is by far not as pronounced as in the RES of 
liver and spleen. Sphingomyelins separate in TLC into two 
bands, sphingomyelins containing the unsaturated long 
chain base sphingosine (lower Rf value; lower band) and 
those with dihydrosphingosine (higher Rf value; upper 
band). They are both substituted with fatty acids of chain 
lengths C16 to C24. Cerebrosides and sulfatides also split 
into bands, however, owing to their acyl groups; The bands 
with lower Rf values are the e-hydroxy fatty acids, those 
with higher Rf values the n-fatty acid-substituted galacto- 
sylceramides. 
Homozygous asmase  -/- Mice Show 
Severe Hepatosplenomegaly 
Inspection of the parenchymous organs ofthe opened ab- 
domen of wild-type mice and hetero- and homozygous 
aSMase-deficient mice revealed an enlarged liver and 
spleen in the homozygous mice. The wet weight of the 
total liver of homozygous asmase  -~- mice had increased 
about 1.5 times, and that of the spleen varied but often 
reached twice the weight of age- and sex-matched wild- 
type mice in the final stage. The sacrificed mice were im- 
mediately perfused with 4% paraformaldehyde in phos- 
phate.buffered saline (PBS), and liver, spleen, lung, and 
brain were excised and postfixed for paraffin or cryo- and 
ultrathin sections for electron microscopy. 
In histology, Kupffer cells of liver and hepatocytes are 
swollen and have a foam cell appearance, with extended 
vacuolation throughout the whole cytoplasm. The nucleus 
of RES cells appears to be dislocated by the globular or 
vesicular structures to the periphery. Figure 5a presents 
the histology of a liver acinus of a wild-type (upper left) 
and a homozygous asmase  -~- mutant mouse (right). 
Arrows point o Kupffer cells loaded with sphingomyelin 
(foam cells). In electron microscopy, the Kupffer cell, given 
here as a representative example of the foam cell morphol- 
ogy of the macrophage RES of the asmase-null mutant, 
reveals that lysosomes are filled with stacked membranes 
of stored sphingomyelin, forming myelin figures (Figure 
5B). The red pulp of spleen is filled with large, only faintly 
stained foam cells (Figure 5, center). Numerous megakar- 
yocytes scattered through the red and white pulp can be 
seen at lower magnification. 
Alveoli of the lungs of homozygous mice are clotted with 
nodular, diffuse reticulate infiltrations that consist of lipid- 
loaded histiocytes. Alveoli of the lungs of wild-type mice 
(Figure 5, left) are compared with those of mutant mice 
lacking aSMase (right). 
Ganglion cells of homozygous mice in gray matter of 
the central nervous system (CNS) are frequently swollen 
with pale vacuolation in cytoplasm. The cortical structure 
appears slightly disrupted, owing to }'he loss of cells in the 
cerebral and cerebellar cortex. A slight gliosis is seen in 
gray and white matter. 
The endothelium of the plexus chorioideus is swollen 
and heavily loaded with foam cells. Hqmogeneously 
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Figure 5. Cells of the RES Macrophage System of Liver, Spleen, and 
Lung Are Transformed to Lipid-Loaded Foam Cells 
(A) Liver from wild-type mice (left) and from homozygous aSMase- 
deficient mice (right). Arrows mark some of the RES foam cells (en- 
larged Kupffer cells), the nuclei of which are dislocated to the periphery 
by sphingomyelin-loaded lysosomes. The spleen of the wild-type 
mouse (left) shows a regular pulp. In homozygous mutants (right), the 
red pulp is disrupted by interspersed foam cells and many megakaryo- 
cytes. Lung alveoli of homozygous mutant mouse (right) are clotted 
with histiocytes that are degenerated to large lipid-loaded foam cells. 
Left, wild-type mouse. Sections (3-5 p.m) of liver and lung were stained 
with hematoxylin-eosin; sections of spleen were stained with PAS. 
Scale bar, 80 p.m. 
(B) Electron microscopy of Kupffer cell in the liver of asmase  -~- mice. 
The cell is filled with lysosomes packed with stacked membraneous, 
myelin-like structures consisting of stored sphingomyelin. 
stained, isolated large cells are loosely deposited within 
the spinal fluid space of the plexus. 
The most striking observation is the progressive and 
finally complete degeneration of the Purkinje cell stratum 
(Figure 6), which occurs within 60-90 days after birth in 
homozygous mice. Few residual Purkinje cells are persis- 
tent; these are packed with lipid-loaded lysosomes. They 
have lost their flask-shaped form, and their nuclei are in 
the process of lysis. At earlier stages, more Purkinje cells 
with the foam cell morphology are seen, indicating the 
progression of the storage disease with age predomi- 
nantly, if not selectively, in this cell layer. The loss of the 
Purkinje cell layer explains the severe impairment of motor 
coordination described below and known as cerebellar 
ataxy. 
Figure 6. Purkinje Cells of Homozygous Mutant aSMase-Deficient 
Mice Degenerate Selectively and Completely 
Section of cerebellum of control wild-type mice (left). Flask-shaped 
Purkinje cells line up as a single ganglionic stratum in the deepest 
part of the molecular layer adjacent to the granular cell layer of cerebel- 
lum. In the homozygous mouse (right), only a few residual degenerated 
Purkinje cells are visible. The bordering ranular layer appears irregu- 
lar; granular cells have normal appearance. Sections (3-5 pro) of cere- 
bellum were stained with luxol-cresyl violet. Scale bar, 80 p.m. 
Cerebellar Motor Coordination Is Lost 
in asmase Mutant Mice 
Cerebellar ataxy is the dominant neuropathological symp- 
tom. Locomotor ataxy is evidenced by the ataxic gait and 
the intention tremor. We documented the cerebellar ataxic 
gait by the hind foot pattern (Aiba et al., 1994) of wild-type 
and of two aSMase-deficient mutant mice at age 90 days 
after birth (Figure 7). The gait is straddle-legged. Lines at 
the bottom of Figure 7 mark the average distance between 
the print of the left and the right hind "foot. The pattern 
also visualizes the contact of the foot sole with widespread 
toes and the plantar part of hind feet. The steps are shorter, 
as indicated by the average distance between foot prints. 
We used the rotarod test for testing the motor coordina- 
tion. Cerebellar motor coordination decayed along with 
the loss of Purkinje cells. At postnatal day 50, the motor 
deficit of mutant mice became apparent. Mutant mice 3-4 
months old were unable to stay on the resting or extremely 
slowly rotating rod (Figure 8). 
Discussion 
The molecular basis of Niemann-Pick disease with the 
massive storage of sphingomyelin in the lysosomes of 
RES cells is confined to alterations of the asmase gene. 
This results in a change of the primary structure and re- 
duced catalytic activity of aSMase. Following the isolation 
of asmase and the cloning of asmase-specific cDNA, sev- 
eral point mutations have been defined in asmase of fibro- 
blasts isolated and cultured from Niemann-Pick disease 
patients. In most cases, the level of aSMase activity is 
greatly reduced. The wide range of phenotypes of late 
onset neurovisceral sphingomyelinosis variants with re- 
sidual activity of a mutant asmase may be reconciled on 
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Figure 7. Gait Pattern of Wild-Type and asmase + Mice 
Hind foot pattern of wild-type (lane 1) and homozygous 90-day-old 
mutant mice (lanes 2 and 3). Mutant mice walk in short steps with a 
wide base between their hind feet. Bars under the foot pattern refer 
to ther~arrow traces of wild-type hind footprints and those of two mutant 
mice of the same age. Footprints also indicate a broad stabilizing 
plantar contact with widespread toes. A straightforward movement of
the mutant mice is only possible between arrow barriers lining the 
pathway. 
the basis of a kinetic model that correlates the residual 
activity with the rate of degradation of sphingomyelin i  the 
lysosome (Conzelmann and Sandhoff, 1991). The variant 
phenotype of Niemann-Pick disease has also been taken 
as an argument for the presence of aSMase isoenzymes 
(Callahan and Khalil, 1976). 
However, neither the numerous point mutations in the 
asmase  gene nor the few genetically uncharacterized ani- 
mal models have so far allowed an unambiguous definition 
of the asmase  -~- phenotype. 
asmase  + Mice Develop Severe Sphingomyelin 
Storage Disease 
We generated a mouse model with a complete lack of the 
lysosomal (acid) sphingomyelinase (Niemann-Pick mouse) 
to study the molecular and cellular basis of the complete 
loss of aSMase, particularly with respect to the involve- 
ment of the CNS. 
The targeting const ruct  introduced into ES cells by ho- 
mologous recombination replaced the asmase  gene. The 
resulting asmase-nu l l  mutant showed a complete absence 
of asmase  mRNA in Northern blot hybridization analysis 
in all tissues studied. Consequently, all tissues of the ho- 
mozygous mutant mice are completely devoid of aSMase 
+/+ 
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Figure 8. Rotarod Test Shows Impaired Motor Coordination 
Motor coordination declines with age in parallel with the degeneration 
of the Purkinje cell layer. Whereas wild-type mice (n = 6) remain 
on the rotating rod for the times indicated, the mutant mi~e beyond 
postnatal day 50 fell from the rod rotating at 8 rpm immediately. At
the age of 4 months, they were no longer able to stay on the rod rotating 
at 0.4 rpm; some were not even able to stay on the resting rod. 
activity. Owing to the lack of the enzyme, the homozygous 
mutant mouse develops a severe sphingomyelin storage 
in the lysosomes of the RES macrophage system, which 
appear morphologically as large subcellular vesicular 
structures. They are filled with stacked membrane-like 
structures (myelin figures), as seen through the electron 
microscope, similar to those described previously in the 
liver of Niemann-Pick patients (Brady, 1987) (Figure 5B). 
Sphingomyelin storage is generalized in the RES cells, 
particularly in visceral organs, here documented for liver, 
spleen, and lung (Figure 5A). 
The massive storage of sphingomyelin in histiocytes 
(foam cells) in the lung leads to diffuse reticular and nodu- 
lar infiltrations with obstruction of the alveoli, which causes 
severe pulmonary incapacitance. 
Complete Degeneration of Purkinje Cell Stratunl 
in asmase  + Mice 
Besides the widely distributed storage of sphingomyelin 
in neuronal and glial cells, the most ,striking observation 
in CNS morphology of the aSMase-deficient homozygous 
mouse is the complete degeneration of the Purkinje cell 
stratum in the cerebellum. The degeneration of Purkinje 
cells is a rapidly progressing process, the first signs being 
observed during postnatal week 10. It explains the ataxic 
gait and intention tremor. The rapid deterioration of motor 
coordination with age is documented in the rotarod test. 
The asmase  + mice fail with increasing age to stay on the 
slowly rotating or resting rod. 
Perspectives 
The question remains why Purkinje cells selectively and 
not all neurons and gila cells manifest massive sphingomy- 
elin storage with subsequent cell death. Is it the enhanced 
membrane turnover of Purkinje cells? Their neuronal ac- 
tivity exceeds by far that of most other cell types of the 
CNS, owing to their prominent role in mot~)r plasticity (Kon- 
nerth et al., 1990). Purkinje cells of the cerebellar cortex 
form excitatory and inhibitory synapses with parallel and 
climbing fibers on the excitatory side and from basket cells 
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on the inhibitory side. Sensory information is relayed from 
all parts of the body via mossy fibers to numerous granular 
cells. In addition, single afferent climbing fibers from the 
ol ivocerebellar tract transmit excitatory inputs directly to 
the Purkinje cell. Further studies on the correlation be- 
tween neuronal activity and turnover of cellular compo- 
nents, particularly of the plasma membrane,  are nec- 
essary. 
Beyond the function of aSMase in the degradation of 
sphingomyelin during the disassembly and degradation 
of endocytosed membranes, the question arises whether 
the lack of aSMase interferes with the emerging functions 
of sphingolipids such as ceramides, long chain bases 
sphingosine and dihydrosphingosine, and sphingosine 
phosphate as second messengers in signal transduction 
pathways. Sphingomyel in degradation could be a main 
source of these intermediates. 
Ceramide-mediated cellular responses to this putative 
second messenger molecule are rapidly emerging (for re- 
view, see Divecha and Irvine, 1995). It has been reported 
that neutral and acid sphingomyel inases play a pivotal 
role in producing ceramides that function as lipid second 
messengers in tumor necrosis factor (TNF)-induced sig- 
naling and that the two sphingomyel inases with neutral 
(Spence, 1993) and acidic pH optima (Chatterjee, 1993), 
respectively, are activated independently by a 55 kDa TNF 
receptor (TNF-R'I') complex, aSMase supposedly triggers 
the nuclear translocation and activation of the NF-KB 
(Machleidt et al., 1994). TNFa-stimulated release of cera- 
mide has been implicated in the activation of membrane-  
activated protein kinases (Mathias et al., 1991), inthe mito- 
gen-activated protein kinase cascade (Raines et al., 1993), 
and in the TNF-induced cell killing (Jarvis et al., 1994; 
Obeid et al., 1993). Recently, a functional dichotomy of 
the plasma membrane-bound nSMase and the lysosomal 
aSMase in TNF signaling has been proposed (Wiegmann 
et al., 1994). This implies the activation of the two sphingo- 
myelinases in different cell compartments, the neutral 
SMase in the plasma membrane and the acid SMase in the 
endosome/lysosome. The topological separation imposes 
some unanswered questions on this concept. 
The asmase  -~- mouse line described here is a geneti- 
cally and phenotypical ly well-defined mimicry of the neu- 
rovisceral form of the human sphingomyel inase storage 
disease, N iemann-P ick  disease. This mouse model ex- 
plains the CNS involvement on a cellular level, although 
the molecular mechanism of the selective and early death 
of Purkinje cells awaits clarification. The asmase  mutant 
mouse might be a useful model to study many open funda- 
mental questions that arise not only from the divergent 
topology of the two sphingomyelinases that release cera- 
mide from sphingomyel in as the second messenger in the 
signaling pathways mentioned before. As shown in this 
report, neutral sphingomyel inase expression is not im- 
paired in the asmase  + mouse tissues. 
Finally, the mutant mouse deficient in the so-called 
housekeeping enzyme aSMase might provide a suitable 
experimental model for the development of strategies in 
somatic gene therapy. 
Experimental Procedures 
Homologous Recombination of ES Cells 
The molecular cloning of a 4.8 kb genomic SamHI fragment harboring 
the complete asmase gene of the mouse and the organization and 
complete nucleotide sequence of the gene have been described pre- 
viously (Newrzella and Stoffel, 1992). It was isolated from a BALB/c 
mouse genomic EMBL3 phage library by using a complete mouse 
asmase cDNA clone isolated from a mouse liver cDNA Zgtl 1 library 
(Clontech, ML 1035b). The complete mouse asmase gene starting 
-780 bp upstream of the start codon and ending 160 bp distal to the 
polyadenylation signal was subcloned into p UC19 (Newrzella and Stof- 
fel, 1992). The targeting construct was prepared by ligation of the blunt 
end 1.2 kb neo gene with its thymidine kinase (tk) promoter into the 
blunt end Bcll site of exon III of the asmase gene. The tk gene (Xhol- 
BamHI 1.8 kb fragment) was ligated into the multiple cloning site of 
pUC19 at the 5' end of the 4.8 kb asmase gene. The structure of the 
targeting vector is given in Figure la. 
E14 ES cells (107) were mixed with a 15-20 I~g Xhol fragment re- 
leased from the targeting vector and transfected by electroporation 
at 250 V and 500 IIF using a Bic-Rad gene pulser (Ramirez-Solis et 
al.. 1993). The selection medium containing G418 (200 p.g/ml) and 
gancyclovir (0.2 p.M) was added to the medium 24 hr after the electro- 
poration. Resistant ES clones were selected 10 days after the transfec- 
tion. The homologous recombination event was assessed by Southern 
blot hybridization analysis and PCR analysis of genomic DNA. DNA 
was prepared according to the protocols of Laird et al. (1991). 
Generation of aSMase-Deficient Mice 
Chimeric mice were generated by injection of four ES cell clones into 
blastocysts of C57BL/6 donor mice as described by Bradley (1987). 
They were intercrossed with C57SlJ6 mice and screened for agouti 
offspring. Germline transmission was assessed by Southern blotting. 
Heterozygous aSMase-deficient mice were interbred to homozygosity. 
The asmase + male and female were fertile up to the age of 3-4 
months. 
Southern Blot Analysis 
Genomic DNA of ES clones and tail DNA of chimeric mice were re- 
stricted with EcoRI for the analysis of homologous recombinants. A 
3 kb EcoRI fragment was released from the homologously recombined 
asmase gene and a 2.3 kb EcoRI fragment from the endogenous gene. 
Restriction enzyme cleavage sites in the construct, the adjacent 
genomic sequences, and the positions of the primers for the PCR are 
indicated in Figure 1A. 
PCR Analysis 
PCR of tail DNA of wild-type, heterozygous, and homozygous mice 
was carried out with 1 p.g of genomic DNA and 20 pmol each of primers 
neo 3' (5'-AGCGCATCGCCTTCATCGCCTTCTrGACG-3') and Ex6A 
(5'-AGTCTGGAACATGGAATACTAGCACAACAG-3'). After 4 min of 
denaturation at 94°C, 35 cycles were run with the following tempera- 
ture program: 1 rain at 93°C, 1.5 min at 68°C, 2 rain at 72°C, and 
finally one cycle was run for 10 min at 72°C. Homologous recombined 
DNA inserts yielded the expected 1.55 kb PCR fragment (Figure 1B). 
Northern Blot Analysis 
Total RNA was isolated by the single-step guanidinium thiocyanate- 
phenol method (Chomczynski and Sacchi, 1987). RNA (30 p.g) from 
liver, spleen, brain, and lung was heat-denatured and size-fractionated 
by electrophoresis through a 1.2O/o formaldehyde-agarose g l and 
transferred onto a nitrocellulose membrane by capillary blotting. The 
baked filter (2 hr at 80°C) was prehybridized for 4 hr and hybridized 
with a randomly ~P-labeled Hindlll fragment (nucleotides 188-1965) 
of mouse asmase cDNA (107 dpm/p.g), washed according to the instruc- 
tions of the supplier, and autoradiographed. The filter was simultane- 
ously hybridized with a randomly labeled GAPDH cDNA probe (548 
bp HindllI-Xbal fragment). 
Acid and Neutral Sphingomyelinase Assay in Different Tissues 
Liver, spleen, and brain of wild-type mice and hetero- and homozygous 
aSMase-deficient mice were homogenized in 2 vol of 10 mM Tris-HCI 
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(pH 7.2), 0.1% N P-40, and 5 U of Trasylol (Bayer) in a Waring blender. 
The homogenata was stirred for 1 hr at 4°C and centrifuged at 
18,000 × g for 45 rain. The supernatant was used for the enzyme 
assay. 
Protein was determined with the bicinchoninic acid (BCA) protein 
assay reagent, according to the instructions of the manufacturer 
(Pierce, Rockford, IL). [Methyl-14C]sphingomyelin (Stoffel et al., 1971) 
(8000 dpm/nmol) was dissolved at a concentration of 1 nmol/p.I in 0.1 
M sodium acetate (pH 4.5), 0.1O/o NP-40. The substrate solution (10 
p.I) was incubated with 10 p.I and 20 p.I of enzyme solution, respectively, 
and diluted to 200 pJ with the above buffer and incubated for 1 hr at 
37°C. To this, 100 p.I of 0.10/o phosphocholine was added. For nSMase, 
the homogenate (600 x g) of liver, spleen, and brain of wild-type mice 
and homozygous mutant mice was used as enzyme source. The assay 
was carried out under the same conditions as described for aSMase, 
but substituting the pH 4.5 acetate buffer by a 0.1 M Tris-HCI (pH 
7.4), 2 mM MgCI2, 0.1% NP-40 buffer. Ceramide and excess substrate 
were extracted with 800 p.I of chloroform-methanol (2:1 v/v). Aliquots 
(100 pl) of the aqueous phase were counted in 10 ml of Bray solution 
in a scintillation counter. 
Lipid Analysis 
Total Lipid Extracts 
Specimens of liver, spleen, and brain of wild-type mice and hetero- 
and hornozygous aSMase-deficient mice were homogenized in 10 vol 
of chloroform-methanol (2:1 v/v) with an ultraturrax. The homogenate 
was centrifuged at 600 x g, the clear supernatant collected, and the 
extraction repeated. The combined supernatant was evaporated to 
dryness on a rotary still, Lipids were dissolved in equal volumes of 
chloroform-methanol (2:1). 
Alkaline Hydrolysis of Lipids 
Aliquots of the total lipid extract were saponified in 1 ml of 0.5 N 
methanolic KOH at 37°C for 4-6 hr. Water (0.5 ml) was added and 
the mixture extracted three times with chloroform. Phases were sepa- 
rated by centrifugation. The combined chloroform extracts were con- 
cent~tated to dryness. Aliquots of total and alkali-stabile lipids were 
streaked on coated high performance TLC plates for separation with 
the solvent system chloroform-methanol-water, 65:25:4. Phospho- 
lipid bands were visualized by spraying the plate with Zinzadze reagent 
(Dittmer and Lester, 1964). For fatty acid analysis, the two sphingomya- 
lin bands (Figure 4) were scraped from the plates, separately trans- 
ferred into small Sovirel tubes, and transesterified with 50/o (w/w) math- 
anolic HCI (1 ml) at 80°C for 4 hr under nitrogen. Water (1 ml) was 
added, and fatty acid methylastars were extracted twice with 1 ml of 
hexane. The solvent was evaporated in a stream of nitrogen. The fatty 
acid methylesters were dissolved in chloroform for gas chromatogra- 
phy: a capillary column (15 m), coated with D B-225 (J and W Scientific), 
was used in a model 8000 GLC apparatus Erba, with helium as carrier 
gas. A temperature program (5°C/rain) between t80°C and 200°C 
was run. 
Histology 
Wild-type mice and hetero- and homozygous aSMase-deficient mice 
of different ages were sacrificed in a CO2 atmosphere. Upon inspection 
of the opened abdomen, liver and spleen of the homozygous mice 
appeared enlarged and slightly yellowish. Mice were immediately per- 
fused with 20 ml of 2.5% paraformaldehyde in PBS through the left 
ventricle of the heart with the right atrium opened. Liver, spleen, lung, 
intestine, and brain were excised and postfixed for an additional 12 hr 
in the same fixative. They were paraffin embedded, following standard 
procedures. Microtome sections (3-6 p~m) were mounted on polylysine- 
coated slides and stained with hematoxylin-eosin, cresyl violet, peri- 
odic acid-Schiff reagent (PAS), or luxol-cresyl violet as indicated in 
the legends to figures. 
Neuromotor Activity Tests 
The rotarod test was carried out with a rotarod apparatus manufactured 
in the local machine shop. It consisted of a plastic rod (3 cm diameter) 
with a gritted surface. Compartments of 10 cm on the rod were sepa- 
rated by discs 30 cm in diameter. The rod was rotated by a step motor 
at speeds of 0.4, 0.8, 1.6, 4.0, and 8.0 rpm. Groups of age-, size-, 
and sex-matched wild-type and mutant mice were studied. They were 
placed on the rod in separated compartments, and the time each 
mouse remained on the rod at defined speeds of rotation was mea- 
sured. Times of repeated experiments were averaged. 
Footprint analyses were carried out as described (Aiba et al., 1994). 
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